IGF2BP1 and neoplasm: Other factors, including age (OR = 1.01, p = 0.816), tumor size (OR = 1.13, p = 0.466), tumor grade (moderately differentiated: OR = 0.78, p = 0.838; poorly differentiated: OR = 0.22, p = 0.208), and FIGO stage (stage III: OR = 0.27, p = 0.161) were not significantly associated with IGF2BP1 expression.